• europages
  • >
  • COMPANIES - SUPPLIERS - SERVICE PROVIDERS
  • >
  • biotechnologies

Results for

Biotechnologies

BelgiumGhent and East Flanders
  1. GULLIVER BIOMED BV

    Belgium

    The company GULLIVER BIOMED BV, is a Service Provider, which operates in the Biotechnologies industry. It is based in Ghent, Belgium.

  2. VIB (VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE)

    Belgium

    The company VIB (VLAAMS INSTITUUT VOOR BIOTECHNOLOGIE), is a Service Provider, which operates in the Scientific research centres and laboratories industry. It also operates in the Biotechnologies, and Biotechnologies industries. It is based in Gent, Belgium.

  3. BIOMIX

    Belgium

    The company BIOMIX, is a Retailer, which operates in the Biochemistry - products industry. It also operates in the organic products, and environmental treatment industries. It is based in Belsele, Belgium.

  4. CROPDESIGN

    Belgium

    The company CROPDESIGN, is a Service Provider, which operates in the Environmental research industry. It also operates in the ORGANIC FARMING, Crop services, research & development studies in the agricultural and zootechnical sector, ORGANIC FARMING, Crop services, and biotechnology consultants industries. It is based in Zwijnaarde, Belgium.

  5. SEPS PHARMA

    Belgium

    The SEPS Pharma group provides advanced drug product development services to the leading pharmaceutical and biotechnology companies and is dedicated to the development of innovative drug delivery systems serving solutions to enhance bioavailability and control drug release. The group offers a full suite of drug development services encompassing preclinical development, preformulation development, formulation development, analytical development, dosage forms development, scaling-up and clinical trial manufacturing of small molecules and biopharmaceuticals for oral, pulmonary, nasal and parenteral delivery. The company is dedicated to the development of innovative drug delivery systems serving solutions to enhance bioavailability and control drug release for difficult-to-formulate drug candidates.